연구동향 분석

특집 : HLA 불일치 동종조혈모세포이식

김희제 ( Hee Je Kim ) 2014년

논문상세정보
인용/피인용
' 특집 : HLA 불일치 동종조혈모세포이식' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • bmt
  • gvhd
  • haplotypemismatch
  • t-cellrepleteordepletion
  • t-세포비제거혹은제거
  • unrelateddonor
  • 비혈연공여자
  • 완전일배체불일치
  • 이식편대숙주병
  • 조혈모세포이식
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
32 0

0.0%

' 특집 : HLA 불일치 동종조혈모세포이식' 의 참고문헌

  • 한국인 성인 급성골수성백혈병 환자에서의 살해세포 면역글로불린양 수용체의 분석
    김희제 Blood Research 41 (3) : 1 ~ 1 [2006]
  • 다국적 비혈연 공여자를 이용한 급성골수성백혈병에서의 조혈모세포이식
    김희제 Blood Research 42 (2) : 3 ~ 3 [2007]
  • 고용량의 CD34 양성 조혈모세포와 새 전처치법을 이용한 성골수성백혈병 환자의 혈연간 HLA 불일치 동종이식
    김희제 Blood Research 38 (4) : 1 ~ 227 [2003]
  • donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program
    McGlave PB Blood 95 : 2219 ~ 2225 - [2000]
  • Use of partially mismatched related donors extends access to allogeneic marrow transplant
    Henslee-Downey PJ Blood 89 : 3864 ~ 3872 - [1997]
  • Unrelated hematopoietic stem cell donor matching probability and search algorithm
    Tiercy JM Bone Marrow Res 2012 : 695018 ~ [2012]
  • Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction
    Kanda J Leukemia 27 : 286 ~ 294 - [2013]
  • Typing by nested PCR-SSP approach raises a question about the feasibility of using this technique for detecting fetomaternal microchimerism
    Cho BS Leukemia 20 : 896 ~ 898 - [2006]
  • Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
    Aversa F N Engl J Med 339 : 1186 ~ 1193 - [1998]
  • Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
    Rachamim N Transplantation 65 : 1386 ~ 1393 - [1998]
  • The biological significance of HLA-DP gene variation in haematopoietic cell transplantation
    Petersdorf EW Br J Haematol 112 : 988 ~ 994 - [2001]
  • The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia
    Kim HJ Transplantation 84 : 1082 ~ 1091 - [2007]
  • Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
    Giebel S Blood 102 : 814 ~ 819 - [2003]
  • Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia
    Kim HJ Biol Blood Marrow Transplant 15 : 704 ~ 717 - [2009]
  • Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays
    Tiercy JM Transpl Immunol 10 : 215 ~ 221 - [2002]
  • Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
    Ballen KK Blood 119 : 1972 ~ 1980 - [2012]
  • Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
    Lee KH Blood 118 : 2609 ~ 2617 - [2011]
  • Polymorphism, recombination, and linkage disequilibrium within the HLA class II region
    Begovich AB J Immunol 148 : 249 ~ 258 - [1992]
  • Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient
    Petersdorf EW Blood 92 : 3515 ~ 3520 - [1998]
  • One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation
    Thomas ED Blood 49 : 511 ~ 533 - [1977]
  • Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
    Farag SS Blood 100 : 1935 ~ 1947 - [2002]
  • Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation
    Fernández-Viña MA Blood 121 : 4603 ~ 4610 - [2013]
  • Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation
    Varney MD Hum Immunol 60 : 532 ~ 538 - [1999]
  • Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center
    Wang Y Cancer 119 : 978 ~ 985 - [2013]
  • Killer immunoglobulin-like receptor gene distribution in Guangdong Han population
    Yin XL Di Yi Jun Yi Da Xue Xue Bao 24 : 1416 ~ 1418 [2004]
  • Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vshost disease after unrelated hematopoietic stem cell transplantation in Koreans
    Kim SY Tissue Antigens 69 (1) : 114 ~ 117 - [2007]
  • Improving outcomes in umbilical cord blood transplantation: state of the art
    Cutler C Blood Rev 26 : 241 ~ 246 [2012]
  • Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor
    Beatty PG Transplantation 60 : 778 ~ 783 - [1995]
  • Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods: a retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation
    Kanda Y Br J Haematol 161 : 566 ~ 577 - [2013]
  • Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome
    Flomenberg N Blood 104 : 1923 ~ 1930 - [2004]
  • Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation
    Petersdorf EW Semin Hematol 42 : 76 ~ 84 - [2005]
  • High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
    Kawase T Blood 110 : 2235 ~ 2241 - [2007]
  • Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin
    Lee KH Biol Blood Marrow Transplant 15 : 61 ~ 72 - [2009]
  • Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution
    Kim HJ Bone Marrow Transplant 35 : 959 ~ 964 - [2005]
  • Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia
    Koh KN Br J Haematol 157 : 139 ~ 142 - [2012]
  • Haploidentical 'megadose' CD34+cell transplants for patients with acute leukemia
    Martelli MF Leukemia 16 : 404 ~ 405 - [2002]
  • HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
    Luznik L Biol Blood Marrow Transplant 14 : 641 ~ 650 [2008]
  • HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1
    Venstrom JM N Engl J Med 367 : 805 ~ 816 - [2012]
  • HLA-C mismatch is associated with inferior survival after unrelated donor non myeloablative hematopoietic stem cell transplantation
    Ho VT Bone Marrow Transplant 37 : 845 ~ 850 - [2006]
  • HLA 부적합 동종 조혈모세포이식
    김희제 Blood Research 42 (1) : 1 ~ 1 [2007]
  • Full haplotypemismatched hematopoietic stem cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse
    Franco A J Clin Oncol 23 : 3447 ~ 3454 [2005]
  • Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia
    Im HJ Biol Blood Marrow Transplant 19 : 754 ~ 759 - [2013]
  • Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor
    Morishima Y Biol Blood Marrow Transplant 13 : 315 ~ 328 - [2007]
  • Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
    Ruggeri L Science 295 : 2097 ~ 2100 - [2002]
  • Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program
    Sasazuki T N Engl J Med 339 : 1177 ~ 1185 - [1998]
  • Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors
    Anasetti C Transfus Sci 15 : 221 ~ 230 - [1994]
  • Early apoptosis in CD34+cells as a potential heterogeneity in quality of cryopreserved umbilical cord blood
    Shim JS Br J Haematol 135 : 210 ~ 213 - [2006]
  • Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups
    Norman PJ Immunogenetics 52 : 195 ~ 205 - [2001]
  • Distribution of killer cell immunoglobulin-like receptors in the Greek population
    Niokou D Hum Immunol 64 : 1167 ~ 1176 - [2003]
  • Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling
    Akatsuka Y Br J Haematol 123 : 671 ~ 675 - [2003]
  • Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires
    Crum KA Tissue Antigens 56 : 313 ~ 326 - [2000]
  • Conflicting impact of alloreactive NK cells on transplantation outcomes after haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences
    Zhao XY Biol Blood Marrow Transplant 17 : 1436 ~ 1442 - [2011]
  • Conditioning including antithymocyte globulin followed by unmanipulated HLAmismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
    Lu DP Blood 107 : 3065 ~ 3073 - [2006]
  • Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia
    Cho BS Biol Blood Marrow Transplant 18 : 1552 ~ 1563 - [2012]
  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience
    Goker H Transfus Apher Sci 49 : 590 ~ 599 - [2013]
  • Bone-marrow transplantation (second of two parts)
    Thomas ED N Engl J Med 292 : 895 ~ 902 - [1975]
  • Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision
    Lown RN Bone Marrow Transplant 48 : 210 ~ 219 - [2013]
  • Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors
    Petersdorf EW Blood 89 : 1818 ~ 1823 - [1997]
  • Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia
    Buckner CD Blood 35 : 741 ~ 750 - [1970]
  • Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
    Lv M J Hematol Oncol 5 : 10 ~ - [2012]
  • Algorithm for donor selection in 2011
    Arcese W Curr Opin Hematol 18 : 401 ~ 407 - [2011]
  • A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
    Ciceri F Blood 112 : 3574 ~ 3581 - [2008]
  • A VEGFR-3 antagonist increases IFN-gamma expression on low functioning NK cells in acute myeloid leukemia
    Lee JY J Clin Immunol 33 : 826 ~ 837 - [2013]